| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An overview of the clinical experience with hydroxyurea
|
Donehower, Ross C.
|
|
1992
|
19 |
3S9 |
p. 11-20
10 p.
|
article
|
| 2 |
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia
|
Kolitz, Jonathan E.
|
|
1992
|
19 |
3S9 |
p. 27-33
7 p.
|
article
|
| 3 |
CME test
|
|
|
1992
|
19 |
3S9 |
p. 117-128
12 p.
|
article
|
| 4 |
Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: Summary of an in vitro model and initial clinical pilot experience
|
Albain, Kathy S.
|
|
1992
|
19 |
3S9 |
p. 102-109
8 p.
|
article
|
| 5 |
Enhancement of the loss of multiple drug resistance by hydroxyurea
|
Christen, Randolph D.
|
|
1992
|
19 |
3S9 |
p. 94-101
8 p.
|
article
|
| 6 |
Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix
|
Stehman, Frederick B.
|
|
1992
|
19 |
3S9 |
p. 48-52
5 p.
|
article
|
| 7 |
High-dose hydroxyurea in autologous bone marrow transplantation: A promising “new” agent
|
Vaughan, William P.
|
|
1992
|
19 |
3S9 |
p. 110-116
7 p.
|
article
|
| 8 |
Hydroxyurea and erythropoietin therapy in sickle cell anemia
|
Goldberg, Mark A.
|
|
1992
|
19 |
3S9 |
p. 74-83
10 p.
|
article
|
| 9 |
Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease
|
Dover, George J.
|
|
1992
|
19 |
3S9 |
p. 61-66
6 p.
|
article
|
| 10 |
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer
|
Vokes, Everett E.
|
|
1992
|
19 |
3S9 |
p. 53-60
8 p.
|
article
|
| 11 |
Laboratory and clinical studies of biochemical modulation by hydroxyurea
|
Schilsky, Richard L.
|
|
1992
|
19 |
3S9 |
p. 84-89
6 p.
|
article
|
| 12 |
Mechanism of action of hydroxyurea
|
Yarbro, John W.
|
|
1992
|
19 |
3S9 |
p. 1-10
10 p.
|
article
|
| 13 |
Radiosensitization and cell kinetics: Clinical implications for S-phase-specific radiosensitizers
|
Kinsella, Timothy J.
|
|
1992
|
19 |
3S9 |
p. 41-47
7 p.
|
article
|
| 14 |
Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: The National Institutes of Health experience
|
Rodgers, Griffin P.
|
|
1992
|
19 |
3S9 |
p. 67-73
7 p.
|
article
|
| 15 |
The evolution of hydroxyurea therapy in chronic myelogenous leukemia
|
Kennedy, B.J.
|
|
1992
|
19 |
3S9 |
p. 21-26
6 p.
|
article
|
| 16 |
The place of hydroxyurea in the treatment of primary brain tumors
|
Levin, Victor A.
|
|
1992
|
19 |
3S9 |
p. 34-40
7 p.
|
article
|
| 17 |
Treatment of colon cancer based on biochemical modulation of fluoropyrimidines by hydroxyurea
|
Muggia, Franco M.
|
|
1992
|
19 |
3S9 |
p. 90-93
4 p.
|
article
|
Journal description